Xin Lang Cai Jing·2025-11-13 02:07Group 1 - The core viewpoint of the news is that Dize Pharmaceutical has seen a stock price increase of 5.19%, reaching 64.86 CNY per share, with a total market capitalization of 29.913 billion CNY [1] - Dize Pharmaceutical, established on October 27, 2017, focuses on the research and industrialization of innovative drugs, with 100% of its main business revenue coming from drug sales [1] - The company is located in Wuxi, Jiangsu Province, and has been listed since December 10, 2021 [1] Group 2 - From the perspective of major fund holdings, Dize Pharmaceutical is a top ten holding of the Guotai Haitong Innovation Medicine Mixed Fund A, which reduced its holdings by 30,000 shares in the third quarter, now holding 97,800 shares, accounting for 4.8% of the fund's net value [2] - The fund has a current scale of 1.05 billion CNY and has achieved a year-to-date return of 18.84%, ranking 4567 out of 8145 in its category [2] - The fund manager, Li Zibo, has been in position for nearly 3 years and has achieved a best return of 36.16% during his tenure [3]